{"transactions":[{"id":1412819,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-09-06T21:31:04.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":7987,"price":3.13,"value":24999.31,"ownership":{"direct":false,"nature":"By corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. (\"Mountaineer\") at a purchase price of $3.13 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":7987,"source":{"system":"sec-edgar","filing":"0001415889-24-023026","document":"form4a-09062024_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924023026/form4a-09062024_090901.xml","form_type":"4/A","original_submission_date":"2024-04-24"}},{"id":1437896,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-08-08T20:15:07.000Z","date":"2024-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":9860,"price":6.05,"value":59653.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units."}],"balance_after":104535,"source":{"system":"sec-edgar","filing":"0001415889-24-020979","document":"form4-08082024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924020979/form4-08082024_040801.xml","form_type":"4"}},{"id":1472209,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:11:56.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":295000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001415889-24-017865","document":"form4-06212024_100652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017865/form4-06212024_100652.xml","form_type":"4"}},{"id":1536260,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-04-24T22:54:25.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":7987,"price":3.13,"value":24999.31,"ownership":{"direct":false,"nature":"By corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. (\"Mountaineer\") at a purchase price of $3.13 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":7987,"source":{"system":"sec-edgar","filing":"0001415889-24-011482","document":"form4-04242024_100418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924011482/form4-04242024_100418.xml","form_type":"4"}},{"id":1882812,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Ordinary Shares","published_at":"2023-05-23T01:17:10.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":114395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an award of 114,395 Restricted Share Units (\"RSUs\") on May 18, 2023 (the \"Grant Date\"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":114395,"source":{"system":"sec-edgar","filing":"0001104659-23-063316","document":"tm2316481-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063316/tm2316481-5_4seq1.xml","form_type":"4"}}]}